Targeting anthracyclines in early breast cancer: new candidate predictive biomarkers emerge
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Link
http://www.nature.com/articles/onc2010286.pdf
Reference92 articles.
1. Aas T, Borresen AL, Geisler S, Smith-Sorensen B, Johnsen H, Varhaug JE et al. (1996). Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients. Nat Med 2: 811–814.
2. Andersen CL, Monni O, Wagner U, Kononen J, Barlund M, Bucher C et al. (2002). High-throughput copy number analysis of 17q23 in 3520 tissue specimens by fluorescence in situ hybridization to tissue microarrays. Am J Pathol 161: 73–79.
3. Arriola E, Marchio C, Tan DSP, Drury SC, Lambros MB, Natrajan R et al. (2008). Genomic analysis of the HER2//TOP2A amplicon in breast cancer and breast cancer cell lines. Lab Invest 88: 491–503.
4. Bartlett J, Munro A, Dunn J, Hiller L, Jordan S, Twelves C et al. (2009a). Chromosome 17 polysomy (Ch17) as a predictor of anthracycline response: emerging evidence from the UK NEAT adjuvant breast cancer trial. Cancer Res 69: 45.
5. Bartlett JM, Desmedt C, Munro A, O'Malley FP, Larsimont D, Di Leo A et al. (2009b). Chromosome 17 polysomy: a unifying hypothesis underlying benefit from adjuvant anthracyclines? Cancer Res 69: 6059.
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Predictive Biomarkers in Breast Cancer: ER, PR, and HER-2/NEU;Handbook of Practical Immunohistochemistry;2022
2. Long Non-Coding RNA HOTAIR in Breast Cancer Therapy;Cancers;2020-05-09
3. Anthracycline Use for Early Stage Breast Cancer in the Modern Era: a Review;Current Treatment Options in Oncology;2018-05-11
4. Expression of M2 macrophage markers YKL-39 and CCL18 in breast cancer is associated with the effect of neoadjuvant chemotherapy;Cancer Chemotherapy and Pharmacology;2018-05-04
5. Tumor-associated macrophages in human breast cancer produce new monocyte attracting and pro-angiogenic factor YKL-39 indicative for increased metastasis after neoadjuvant chemotherapy;OncoImmunology;2018-03-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3